Author:
Kaufman H E,Varnell E D,Centifanto-Fitzgerald Y M,De Clercq E,Kissling G E
Abstract
Chronic oral administration of acyclovir or bromovinyl deoxyuridine to rabbits did not prevent recurrence of virus shedding or clinical corneal disease, nor did it alter the clinical course of recurrences of ocular herpetic disease or result in the appearance of resistant virus in tears.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference11 articles.
1. Treatment of experimental herpes simplex virus encephalitis with (E)-5-(2-bromovinyl)-2'-deoxyuridine in mice;De Clercq E.;Antimicrob. Agents Chemother.,1982
2. Development of clinical resistance to acyclovir in herpes simplex virus-infected mice receiving oral therapy;Field H. J.;Antimicrob. Agents Chemother.,1982
3. Gross A. J. and V. A. Clark. 1975. Survival distributions: reliability applications in the biomedical sciences. John Wiley & Sons Inc. New York.
4. Kaufman H. E. 1981. Local therapy of herpes simplex virus ocular infections p. 466-477. In A. J. Nahmias W. R. Dowdle and R. E. Schinazi (ed.) The human herpesviruses: an interdisciplinary perspective. Elsevier/ North-Holland Publishing Corp. New York.
5. Herpes simplex keratitis;Kaufman H. E.;Ophthalmology,1983
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献